Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Zaccaria

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The New England Journal of Medicine|April 23, 2025
Tumor-Infiltrating Clonal HematopoiesisOriol Pich, Elsa Bernard, Maria Zagorulya, et al.
Nature Communications|June 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingSebastijan Hobor, Maise Al Bakir, Crispin T Hiley, et al.
Nature Communications|January 8, 2022
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Medicine|April 12, 2023
Evolutionary characterization of lung adenocarcinoma morphology in TRACERxTakahiro Karasaki, David A Moore, Selvaraju Veeriah, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The New England Journal of Medicine|April 23, 2025
Tumor-Infiltrating Clonal HematopoiesisOriol Pich, Elsa Bernard, Maria Zagorulya, et al.
Nature Communications|June 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doublingSebastijan Hobor, Maise Al Bakir, Crispin T Hiley, et al.
Nature Communications|January 8, 2022
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Communications|August 25, 2021
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatmentHua Sun, Song Cao, R Jay Mashl, et al.
Nature Medicine|April 12, 2023
Evolutionary characterization of lung adenocarcinoma morphology in TRACERxTakahiro Karasaki, David A Moore, Selvaraju Veeriah, et al.
Nature|April 29, 2026
Evolutionary characterization of lung cancer metastasisSonya Hessey, Abigail Bunkum, Ariana Huebner, et al.
Nature|April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERxMaise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
Nature|July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature|April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERxAlexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Pageof 4